A corporate briefing session was conducted through video link facility on Wednesday, September 15, 2022, to brief investors and analysts on the financial results of the Company for the period ended June 30, 2022.
A corporate briefing session was conducted through video link facility on Thursday, April 7, 2022 to brief investors and analysts on the financial results of the Company for the year ended December 31, 2021.
The session was conducted through Zoom on Wednesday, November 03, 2021 to brief Investors and Analysts on financial results of the Company for nine months ended September 30, 2021
AGP wins Top Exporter Award at 6th PPMA Summit
AGP Limited has been presented with the prestigious ‘Top Exporter’ award at the 6th Pakistan Pharmaceutical Manufacturers’ Association (PPMA) Summit held on 12th July, 2023, at Serena Hotel, Islamabad.
This recognition as one of the Top Exporter fuels our determination to continue expanding our global footprint, with the help of our state-of-the-art manufacturing facilities. With the help of our talented team, we look forward to working harder, leading with compassion, and transforming the world of healthcare.
AGP sponsors KDSP Carnival 2023
AGP was a proud sponsor at the Annual KDSP Carnival 2023 to advocate for the right to freedom for people with Down Syndrome and to advocate for their right to be treated fairly and have the same opportunities as everyone else.
AGP bags big win at GDEIB Awards 2023
AGP is delighted to announce its big win at the GDEIB awards for the fourth year in a row! Keeping true to our commitment to DEI, AGP has bagged awards in total of eight categories.
Sincere thanks to HR Metrics and GDEIB for yet again giving us this opportunity to celebrate the things we do to ensure our employees’ comfort and cultivate a culture of trust.
AGP continues partnership with IBA
AGP has continued its partnership with Institute of Business Administration (IBA) to provide quality education to promising students by extending its annual scholarship fund for deserving IBA students.
AGP and IBA had come together in May 2021 to establish the annual scholarship fund. The MOU was signed by Nusrat Munshi, MD & CEO of AGP, and Dr. S. Akbar Zaidi, Executive Director of IBA. Through this initiative, the Company is supporting IBA to make university education accessible to deserving students.
AGP continues collaboration with TCF
AGP has deepened its partnership with The Citizens’ Foundation and has taken the responsibility of supporting a school with 200 students in Jacobabad, which is run by TCF.
The Company is delighted to partner with TCF to help fulfill its mission of providing quality education throughout the country.
AGP joins hands with SKMF
AGP and the Sharmeen Khan Memorial Foundation (SKMF) have joined hands to provide 100 students with high-quality education.
SKMF is committed to helping underprivileged children by ensuring that they receive excellent education.
AGP secures 1st position in Pharma Sector in BCR Awards
AGP has secured 1st position in Best Corporate & Sustainability Report Awards 2021 among the Pharmaceutical Sector, jointly held by Institute of Chartered Accountants of Pakistan (ICAP) and Institute of Cost and Management Accountants of Pakistan (ICMA Pakistan).
This award is a testament of our commitment to best governance and corporate practices along with highest level of integrity and transparency.
AGP continues partnership with ACF
AGP continued its partnership with Ayesha Chundrigar Foundation (ACF) Animal Rescue to play its part in ensuring coexistence of humans and other living creatures.
Through this partnership, AGP will providing essential support to ACF’s Trap, Neuter, Vaccinate, Release/Relocate (TNVR) program for conducting mass vaccination and neutering of stray dogs.
AGP conducts Allergy Awareness Session At Pak Turk Maarif
Pursuant to our ethos to promote health and well-being of the society, AGP conducted an allergy awareness program at Pak Turk Maarif International School on October 22, 2022.
This session aimed to educate staff members to protect children from potentially severe allergies.